Momentum Bioscience

Summary: Momentum is developing a microbial enrichment technology. It seems to be based on selective lysis and filtration. Looks like they’ve raised $20M and have about $3M in the bank.

Momentum Biosciences is a UK based Biotech company, as of October 2024 they seem to have ~$3M USD in the bank. Based on my reading of their accounts and this pitchbook report, they seem to have raised ~$20M since the company was incorporated in 2005.